Summary - SNY - NASDAQ - Weiss Ratings

C

Sanofi SNY

$49.48 -$0.46-0.92% NASDAQ

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

52-Week Range

$44.73 - $60.12

P/E (TTM)

EPS (TTM)

My Lists My Alerts

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

Analysts Can't Get Enough of These Little-Known Biopharma Stocks

6/12/2025 - MarketBeat

Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia

9/1/2025 - Zacks Investment Research

OLD Mission Capital LLC Invests $48.94 Million in Sanofi $SNY

8/31/2025 - MarketBeat

11 Best Pharma Stocks to Invest in for the Long Term

8/31/2025 - Insider Monkey

Sanofi's (SNY) Wayrilz Gains FDA Approval for ITP Treatment

8/30/2025 - GuruFocus

Sanofi wins FDA nod for Wayrilz in bleeding disorder thrombocytopenia

8/30/2025 - Seeking Alpha - Healthcare

Sanofi wins FDA nod for Wayrilz in bleeding disorder thrombocytopenia

8/30/2025 - SeekingAlpha.com: All News

Ameriprise Financial Inc. Purchases 65,231 Shares of Sanofi $SNY

8/30/2025 - MarketBeat

FDA Approval Boosts Prospects for Sanofi's Wayrilz (SNY) in Treating ITP

8/29/2025 - GuruFocus

FDA approves Sanofi's Wayrilz as BTK inhibitor for immune thrombocytopenia

8/29/2025 - TipRanks Financial Blog

FDA approves Sanofi's Wayrilz as BTK inhibitor for immune thrombocytopenia

8/29/2025 - The Fly

Press Release: Sanofi's Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia

8/29/2025 - Globe Newswire

Regeneron and Sanofi's DUPIXENT Study: A Closer Look at EoE Treatment

8/29/2025 - TipRanks Financial Blog

Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day

8/29/2025 - Zacks Investment Research

Sanofi $SNY Shares Purchased by Callodine Capital Management LP

8/29/2025 - MarketBeat

chutes ladders sanofi snags cmo biomarin

8/28/2025 - FierceBiotech.com - Biotech

FDA Approves Updated COVID-19 Vaccines but With Restrictions

8/28/2025 - Zacks Investment Research

Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line?

8/28/2025 - Zacks Investment Research

Should You Continue to Hold Thermo Fisher Stock in Your Portfolio?

8/28/2025 - Zacks Investment Research

Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults

8/28/2025 - Insider Monkey

Recursion Pharmaceuticals, Inc. (RXRX) Expands Rare Disease Pipeline with REV102 Acquisition

8/28/2025 - Insider Monkey

How The American Academy Of Pediatrics Betrayed Children Everywhere

8/27/2025 - Zero Hedge

Workday, Inc. (NASDAQ:WDAY) Q2 2026 Earnings Call Transcript

8/27/2025 - Insider Monkey

sanofi joins report touting importance sustainably paid community health workers

8/27/2025 - FiercePharma

Analysts Think These Stocks Could More Than Double in Value

5/23/2025 - MarketBeat

Income Statement

Total Revenue (TTM)

--

EBITDA (TTM)

--

EBIT (TTM)

--

Net Income (TTM)

--

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

--

Cash from Investing (TTM)

--

Cash from Financing (TTM)

--

Net Change in Cash (TTM)

--

Filings

Filing Date

Thursday, July 31, 2025

Period Date

Monday, June 30, 2025

Next Filing

Week of Oct 20 and 24 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Jul 31, 2025 - $44.73

52-week High

Mar 10, 2025 - $60.12

Valuation

Market Cap

$120.52B - Large Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

Dividend Per Share (TTM)

Corporate Info

Website

Phone Number

33 1 53 77 40 00

Address

46, avenue de la Grande Armée
Paris, 75017

Country

Year Founded

Business Description

Sector

--

Industry

--

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides... more